Getting access to health insurance, and getting access to a doctor, are two very different things. But a new U-M study suggests that the two have gone hand-in-hand in the state of Michigan, despite a rapid influx of hundreds of thousands of newly insured people under the state’s expansion of Medicaid.
It’s a tale of two tests: one for early signs of cervical cancer, the other for a sexually transmitted disease. But a new study suggests that a change in the recommended schedule for one may have dramatically lowered the chances that young women would get the other.
Few people today would dare call President Richard Nixon a radical liberal. But 44 years ago, he proposed a health plan that went far beyond what today’s Affordable Care Act includes. After the first plan failed, he did it again three years later. A new U-M analysis compares his plans with the current Affordable Care Act.
A stroke happens in an instant. And many who survive one report that their brain never works like it once did. But new research shows that these problems with memory and thinking ability keep getting worse for years afterward – and happen faster than normal brain aging.
A new study of emergency stroke care in America shows just how much of a patchwork system we still have for delivering the most effective stroke treatment.
And thousands of people a year may end up unnecessarily disabled as a result.
A physician-scientist whose work has improved quality of life for tens of thousands of Parkinson’s disease patients is the recipient of the 2015 Taubman Prize for Excellence in Translational Medical Science, from the U-M’s A. Alfred Taubman Medical Research Institute.
New legislation just passed by the U.S. House would establish a Medicare demonstration project of a principle called Value-Based Insurance Design (V-BID), a concept born from University of Michigan research that aligns patients’ out-of-pocket costs, such as copayments, with the value -- not the cost -- of health care services.
A free movie screening and panel discussion on June 29 and 30 in Ann Arbor will examine the revolution in digital health - and what needs to happen before patients' medical records are truly available no matter where they go.
It started out as a treatment for arthritis. But steered by science, it could become a first new approach in two decades for treating the damage that diabetes inflicts on the kidneys of millions of people.
Day in and day out, for years on end, millions of people with diabetes prick their fingers to test their blood sugar level. And many may wonder if all the careful eating, exercise and medication it takes to keep those levels under control is really worth it. A major new study should encourage them to keep going for the long haul.
Despite stereotypes about college students resorting to black-market Ritalin to help them cram for exams, young people are actually most likely to start misusing prescription stimulant drugs in their high school years, according to new U-M research.
A survey of women with breast cancer found that nearly half considered having a double mastectomy. But of those who considered it, only 37 percent knew that the more aggressive procedure does not improve survival for women with breast cancer.
Funding from the Mark Cuban Foundation, run by the well-known owner of the Dallas Mavericks, will allow University of Michigan scientists and physicians to study how human growth hormone may aid recovery from an ACL tear
Can a routine hospital stay upset the balance of microbes in our bodies so much that it sets some older people up for a life-threatening health crisis called sepsis? A new U-M/VA study suggests this may be the case.
Mary H. Weiser has watched in terror as her child was gripped by a severe allergic reaction after she ingested a simple food that most of us eat on a daily basis. It’s a moment that the Ann Arbor, Michigan, resident will never forget, and one she’d never wish on anyone.
In a major advance in precision medicine, an international collaboration of researchers found 90 percent of castration resistant metastatic prostate cancers harbored some kind of genetic anomaly that could drive treatment choices.
Why do some cancer cells break away from a tumor and travel to distant parts of the body? A team of oncologists and engineers from the University of Michigan teamed up to help understand this crucial question.
A class of FDA-approved cancer drugs may be able to prevent problems with brain cell development associated with disorders including Down syndrome and Fragile X syndrome, researchers at the University of Michigan Life Sciences Institute have found.
A new urine-based test improved prostate cancer detection – including detecting more aggressive forms of prostate cancer – compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.
Screening to identify Type 2 diabetes followed by early treatment could result in substantial health benefits, according to new research that combined large scale clinical observations and innovative computer modelling.